Myocardial perfusion imaging associated with 31% cost reduction -- clinical study.
This article was originally published in The Gray Sheet
MYOCARDIAL PERFUSION IMAGING ASSOCIATED WITH 31% COST SAVINGS according to results from the Economics of Noninvasive Diagnosis (END) study, presented Nov. 13 at the American Heart Association scientific sessions in New Orleans. Average three-year per-patient medical costs for patients who underwent stress MPI imaging prior to referral for catheterization (n=5,823) was $3,470, $1,571 lower than the average three-year $5,041 per-patient cost for patients who did not receive the cardiac blood flow screening technique (n=5,423).
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.